IP Library Granted Patent US 11,851,666
Granted Patent B2
US 11,851,666 · App. 16/640,776 · Granted Dec 26, 2023

Multi-copy gene protein expression system

Inventors: Clemens Achmüller (Kundl, AT); Norbert Lamping (Holzkirchen, DE); Matjaz Vogelsang (Ljubljana, SI)
C12N15/815C07K14/70578C07K16/00C12N15/85C12P21/02C07K2317/622C07K2319/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,851,666
App. No.
16/640,776
Granted
Dec 26, 2023
Kind
B2
Abstract

The present invention belongs to the field of biotechnology, specifically to the field of recombinant protein expression. The present invention focuses on two problems commonly encountered during recombinant protein expression, low quantity of protein expression and genetic instability of cell lines used for recombinant protein expression. The basic principle of the present invention is to introduce several expression cassettes into a cell which expression cassettes all code for the same mature recombinant protein of interest, but which expression cassettes have different nucleotide sequences. Expression cassette means a polynucleotide sequence which comprises at least a promoter sequence, a start codon, a polynucleotide sequence coding for a protein which is intended to be recombinant expressed (POI), a stop codon and a terminator.

Claims (70)

1. A host cell comprising three or more different types of expression cassettes, each expression cassette coding for the same Protein Of Interest (POI) with identical mature amino acid sequence, and each type of expression cassette at least is comprising a promoter sequence, a polynucleotide sequence of the coding sequence of the POI, a terminator sequence, and optionally a signal sequence, wherein said expression cassettes differ in that they comprise

(A)

(Aa) different promoter sequences,

(Ab) different polynucleotide sequences coding for the identical mature amino acid sequence of the POI due to the use of degenerated genetic code,

and optionally

(Ac) different terminator sequences, and/or

(Ad) different signal sequences, if present,

or wherein said expression cassettes differ in that they comprise

(B)

(Ba) the same promoter sequences,

(Bb) different polynucleotide sequences coding for the identical mature amino acid sequence of the POI due to the use of degenerated genetic code,

and optionally

(Bc) different terminator sequences, and/or

(Bd) different signal sequences, if present,

wherein at least one expression cassette codes for two or more POI with identical mature amino acid sequence, wherein between the coding sequences of said two or more POI is respectively located an internal ribosomal entry site (IRES) sequence.

2. The host cell according to claim 1 , wherein in point (Ab) of alternative (A) of claim 1 said different polynucleotide sequences of the coding sequence of the POI are coded by a degenerated genetic code, which degenerated genetic code results in at least 50% of the maximum theoretical polynucleotide sequence difference possible for that particular POI coding polynucleotide sequence, in order to get an identical mature amino acid sequence of said particular POI,

or wherein in point (Bb) of alternative (B) said different polynucleotide sequences of the coding sequence of the POI are coded by a degenerated genetic code, which degenerated genetic code results in at least 50% of the maximum theoretical polynucleotide sequence difference possible for that particular POI coding polynucleotide sequence, in order to get an identical mature amino acid sequence of said particular POI.

3. The host cell according to claim 1 , wherein in alternative (A) said promoter, said terminator and/or said signal sequences, if present, and in alternative (B) said terminator and/or said signal sequence, if present, respectively differ between the used different expression cassettes by at least 20%, regarding their nucleotide sequence.

4. The host cell according to claim 1 , wherein said POI is heterologous to said host cell.

5. The host cell according to claim 1 , wherein said different polynucleotide sequences of the coding sequences of the POI at least have a length of 30 nucleotides.

6. The host cell according to claim 1 , wherein said host cell is

(i) an eukaryotic cell, selected from

(a) filamentous fungal cells;

(b) yeast cells;

(c) mammalian cells;

(d) human cells;

(e) insect cells;

or

(ii) a prokaryotic cell.

7. A method of generating a host cell as defined in claim 1 , comprising the step of transfecting said host cell with at least three different nucleic acid sequences, wherein each nucleic acid sequence comprises at least one different expression cassette coding for the same mature amino acid sequence of said POI.

8. A method of generating a host cell as defined in claim 1 , comprising the step of transfecting said host cell with at least one nucleic acid sequence, wherein said nucleic acid sequence comprises at least three different types of expression cassettes, and each of said expression cassettes is coding for the same mature amino acid sequence of said POI.

9. A nucleic acid comprising at least three different types of expression cassettes, each expression cassette coding for the same Protein Of Interest (POI) with identical mature amino acid sequence, and each type of expression cassette at least is comprising a promoter sequence, a polynucleotide sequence of the coding sequence of the POI, a terminator sequence, and optionally a signal sequence, wherein said expression cassettes differ in that they comprise

(A)

(Aa) different promoter sequences,

(Ab) different polynucleotide sequences coding for the identical mature amino acid sequence of the POI due to the use of degenerated genetic code,

and optionally

(Ac) different terminator sequences, and/or

(Ad) different signal sequences, if present,

or wherein said expression cassettes differ in that they comprise

(B)

(Ba) the same promoter sequences,

(Bb) different polynucleotide sequences coding for the identical mature amino acid sequence of the POI due to the use of degenerated genetic code,

and optionally

(Bc) different terminator sequences, and/or

(Bd) different signal sequences, if present,

wherein at least one expression cassette codes for two or more POI with identical mature amino acid sequence, wherein between the coding sequences of said two or more POI is respectively located an internal ribosomal entry site (IBES) sequence.

10. A vector comprising at least three different types of expression cassettes, each expression cassette coding for the same Protein Of Interest (POI) with identical mature amino acid sequence, and each type of expression cassette at least is comprising a promoter sequence, a polynucleotide sequence of the coding sequence of the POI, a terminator sequence, and optionally a signal sequence, wherein said expression cassettes differ in that they comprise

(A)

(Aa) different promoter sequences,

(Ab) different polynucleotide sequences coding for the identical mature amino acid sequence of the POI due to the use of degenerated genetic code,

and optionally

(Ac) different terminator sequences, and/or

(Ad) different signal sequences, if present,

or wherein said expression cassettes differ in that they comprise

(B)

(Ba) the same promoter sequences,

(Bb) different polynucleotide sequences coding for the identical mature amino acid sequence of the POI due to the use of degenerated genetic code,

and optionally

(Bc) different terminator sequences, and/or

(Bd) different signal sequences, if present,

wherein at least one expression cassette codes for two or more POI with identical mature amino acid sequence, wherein between the coding sequences of said two or more POI is respectively located an internal ribosomal entry site (IBES) sequence.

11. A kit comprising the nucleic acid as defined in claim 9 and an instruction manual.

12. A process for the manufacture of a POI, comprising

(i) a step of generating a host cell as defined in claim 1 , comprising the step of transfecting said host cell

(A) with at least three different nucleic acid sequences, wherein each nucleic acid sequence comprises at least one different expression cassette coding for the same mature amino acid sequence of said POI,

or

(B) with at least one nucleic acid sequence, wherein said nucleic acid sequence comprises at least three different types of expression cassettes, and each of said expression cassettes is coding for of the same mature amino acid sequence of said POI,

and

(ii) a step of obtaining the POI.

13. The process according to claim 12 , wherein said POI is a single chain protein or originates from a precursor of a single chain polypeptide.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: VOGELSANG, MATJAZ
To: LEK PHARMACEUTICALS D.D.
Reel/Frame 052999/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: LAMPING, NORBERT
To: SANDOZ INTERNATIONAL GMBH
Reel/Frame 052999/0988 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: ACHMUELLER, CLEMENS
To: SANDOZ GMBH
Reel/Frame 053000/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: SANDOZ GMBH
To: SANDOZ AG
Reel/Frame 053000/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: SANDOZ INTERNATIONAL GMBH
To: SANDOZ AG
Reel/Frame 053000/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: LEK PHARMACEUTICALS D.D.
To: SANDOZ AG
Reel/Frame 053000/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2020
From: SANDOZ AG
To: NOVARTIS AG
Reel/Frame 052822/0886 →
Priority Claims (1)
EP 17187552 · Aug 23, 2017 · regional
Continuity (1)
Related Publication 20220025387A1 · Jan 27, 2022